Tirzepatide is a research compound. It is not approved by the FDA or any regulatory body for human use. This article is for educational and informational purposes only. Nothing here constitutes medical advice. Consult a qualified physician before considering any peptide use.
Tirzepatide is typically reconstituted with bacteriostatic water (BAC water). The standard dosage of 5-15 mg weekly is administered once weekly via subcutaneous injection. Use our peptide calculator for exact mixing ratios.
How Do You Reconstitute Tirzepatide?
Tirzepatide is supplied as a lyophilized (freeze-dried) powder that must be reconstituted before use. Proper reconstitution is critical for accurate dosing and maintaining stability.
This guide covers the step-by-step process for mixing Tirzepatide with bacteriostatic water to achieve your target concentration.
What Supplies Do You Need?
To reconstitute Tirzepatide, you need: the Tirzepatide vial (lyophilized powder), bacteriostatic water (BAC water with 0.9% benzyl alcohol), insulin syringes (typically 1mL/100-unit), alcohol swabs, and a clean workspace.
Important: Always use bacteriostatic water — not sterile water or saline. BAC water's benzyl alcohol prevents bacterial contamination, extending the usable life of reconstituted Tirzepatide to 4-6 weeks.
Step-by-Step Tirzepatide Reconstitution
Step 1: Clean the vial tops of both the Tirzepatide and BAC water with alcohol swabs.
Step 2: Draw the calculated amount of BAC water into an insulin syringe. Use our peptide calculator to determine the exact amount.
Step 3: Insert the needle into the Tirzepatide vial at an angle, and let the water run down the side of the glass — never spray directly onto the powder as this can damage the peptide bonds.
Step 4: Gently swirl (do not shake) the vial until the powder is fully dissolved. The solution should be clear.
Step 5: Label the vial with the date and concentration. Store at 2-8°C.
Calculate Your Tirzepatide Dose
Use our free peptide dosing calculator to get exact reconstitution math and syringe units for Tirzepatide.
Open Calculator →How Do You Dose Reconstituted Tirzepatide?
After reconstitution, the standard Tirzepatide dose is 5-15 mg weekly administered once weekly via subcutaneous injection. The number of units on your insulin syringe depends on how much BAC water you added.
Our calculator will tell you exactly how many units to draw for your dose based on your specific reconstitution ratio.
How Do You Store Reconstituted Tirzepatide?
Store reconstituted Tirzepatide at 2-8°C (standard refrigerator temperature). Use within 4-6 weeks. Keep away from light and temperature fluctuations.
Unreconstituted Tirzepatide powder can be stored at -20°C for 12+ months. Once you reconstitute it, the clock starts.
Bottom Line
Reconstituting Tirzepatide is straightforward — add BAC water, swirl gently, refrigerate. The key is using the right amount of water for accurate dosing. Use our peptide calculator every time.
Complete Guide
Tirzepatide : Benefits, Dosage, Side Effects & Research
Related Reading
- Tirzepatide Dosage Guide
- Tirzepatide Benefits
- Tirzepatide Side Effects
- Tirzepatide Stacking Guide
- Tirzepatide Cycle Guide
- Tirzepatide Research
Research-Grade Sourcing
If you're going to research Tirzepatide, source matters. These are the suppliers WolveStack has vetted for purity and third-party testing.
Frequently Asked Questions
What is Tirzepatide?
Tirzepatide (Tirzepatide (GIP/GLP-1 dual receptor agonist)) is a Dual GIP/GLP-1 receptor agonist. Engineered peptide from native GIP sequence with dual affinity for GIP and GLP-1 receptors; developed by Eli Lilly. It is researched for superior weight loss vs GLP-1 monotherapy, glycemic control, cardiovascular improvement, sleep apnea improvement.
What is the recommended Tirzepatide dosage?
Common dosages: 5-15 mg weekly administered once weekly via subcutaneous injection. Cycle length: ongoing with titration over 16 weeks. Half-life: 5 days. Use our peptide calculator for exact reconstitution math.
What are the side effects of Tirzepatide?
GI effects most common — nausea, vomiting, diarrhea/constipation (20-50%, decreasing after 4-8 weeks). Rare pancreatitis and gallbladder events. Retinopathy worsening possible in severe diabetes.
Is Tirzepatide safe?
Tirzepatide has shown a preliminary safety profile in research. FDA-approved (Zepbound for weight, Mounjaro for diabetes). Prescription medication. All research should follow appropriate safety protocols.